AMLXAmylyx Pharmaceuticals, Inc.
$27.20+79% 1Y
$27.20
$11.3852 weeks$39.67
Is the business good?
How good a business is AMLX?
- Share count, year on year
- +25%
Share count, year on year · shareholders own a smaller slice than a year ago
| Year | Operating margin |
|---|---|
| FY2021 | −29013% |
| FY2022 | −906% |
| FY2023 | 10% |
| FY2024 | −360% |
Details›
- Net income, trailing twelve months
- −$152M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
On our screens:Most shorted stocks
Drug Manufacturers, Specialty & Generic
Ranks #39 of 39 by RyuScore